glp-1 rheumatoid arthritis study Medications and Arthritis: What the 2025 Research Actually Shows GLP-1 receptor agonists in rheumatic

Major clinical trials enrolled thousands of participants without identifying depression as a primary safety signal

Ongoing Scheduling Some individuals require regular monthly injections, which may feel inconvenient long-term

It is a reason to approach it with a clinician who understands the literature and who can situate it within your specific metabolic and hormonal profile

Before treatment begins, clinicians review medical history, symptom patterns, and prior therapy response to determine whether PT-141 is a suitable option

Author contributions DyL: Methodology, Conceptualization, Data curation, Validation, Writing original draft